Dr. Barlas Benkli is a Gainesville, Florida based neurologist who is specialized in Neurology. Active license number of Dr. Barlas Benkli is ME167298 for Neurology in Florida. His current practice location is 1600 Sw Archer Rd, Gainesville. Patients can reach him at 352-273-5550 or can fax him at 352-273-5575. Dr. Barlas Benkli is MD in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1750879052. Dr. Barlas Benkli specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Barlas Benkli speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1750879052
NPI Enumeration Date:
23 Apr, 2018
NPI Last Update On:
10 May, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Barlas Benkli are as mentioned below.
License Number
Specialization
State
Status
ME167298
Neurology
Florida
Primary
ME167298
Psychiatry & Neurology
Florida
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Barlas Benkli Po Box 100236, Gainesville, Florida
Zip:
32610-0236
Phone Number:
352-273-5550
Fax Number:
352-273-5575
Patients can reach Dr. Barlas Benkli at 1600 Sw Archer Rd, Gainesville, Florida or can call to book an appointment on 352-273-5550.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.